Navigation Links
Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
Date:4/23/2008

>Disease Background

Metachromatic Leukodystrophy (MLD) is in the family of lysosomal storage diseases (LSD's). MLD is an autosomal recessive disease caused by a deficiency of the lysosomal enzyme arylsulfatase A (ASA) which results in an increased concentration of sulphatide in cells of the brains and in non-neural tissue, such as the kidneys and gallbladder. When these sulfated glycolipids accumulate in the brain, they cause a breakdown of myelin, a substance that protects the nerves in the brains and in the rest of the body. This breakdown is what makes MLD a progressive, neurodegenerative disease.

Symptoms and Patient Outlook

Sulfatide accumulation in the central and peripheral nervous system leads to destruction of the myelin sheath (demyelination). MLD has a spectrum of disease which can arise in infants and young children with a range of symptoms, though most are related to motor and cognitive decline. Most MLD patients are normal at birth but often die before age 20, with some patients within the first few years of life. During the final stages all patients reach a decerebrate, vegetative state. The majority of cases are late infantile or juvenile patients. The number of adult patients exhibiting mild forms of MLD is unknown, as adult onset MLD can present with symptoms similar to psychosis.

SHIRE PLC

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe. Shire believes that a c
'/>"/>

SOURCE Shire PLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
2. Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Hodgkins Lymphoma
3. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
4. US FDA Grants Orphan Drug Status to Immtechs Pafuramidine for Treatment of African Sleeping Sickness
5. Knopp Neurosciences Receives Orphan Designation for KNS-760704 for Treatment of ALS
6. Voices to Unite in Los Angeles for 6,000 Children Orphaned Daily
7. Celldex Therapeutics Announces Orphan Drug Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma Multiforme
8. Insmed Receives FDA Orphan Drug Designation for IPLEX(TM) in the Treatment of Myotonic Muscular Dystrophy
9. Antheras A-001 Receives Orphan Drug Status for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
10. Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate
11. Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... , March 5, 2015  Sanomedics, Inc. (OTC: SIMH, ... company focused on developing, manufacturing, and acquiring cutting-edge technology, ... Thermomedics, Inc., will be exhibiting at booth # 709 ... Conference (NAPNAP) taking place on March 11-13, 2015 ... The 36 th ...
(Date:3/5/2015)... March 5, 2015  Relmada Therapeutics, Inc. (OTCQB: ... the treatment of chronic pain, today announced the ... advisory roles. The panel of experts will provide ... efforts to advance the company pipeline of novel ... expertise in a range of areas including opioid ...
(Date:3/5/2015)... , March 5, 2015 LUNGevity ... the Food and Drug Administration,s (FDA) approval of ... Opdivo and other immunotherapy treatments add another critical ... harnessing the power of a patient,s own immune ... has been approved specifically for patients with squamous ...
Breaking Medicine Technology:Sanomedics to Showcase the Caregiver at National Association of Pediatric Nurse Practitioners Conference 2Sanomedics to Showcase the Caregiver at National Association of Pediatric Nurse Practitioners Conference 3Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 2Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 3Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 4LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 3
... 7, 2011 Johnson & Johnson (NYSE: JNJ ... agreement to become a global sponsor of the 2014 FIFA ... Cup™ Sponsor. With this sponsorship, Johnson & Johnson ... ability to activate across their Consumer, Medical Devices & Diagnostics ...
... Health IT Services Group (HITSG) announced today that its ... this month, continuing its growth as the largest Electronic ... by nephrologists for nephrologists, the Acumen nEHR enables all ... patient information, so that regardless of who treats the ...
Cached Medicine Technology:Johnson & Johnson Announces Global Sponsorship of the 2014 FIFA World Cup Brazil™ 2Acumen nEHR Surpasses 1,000 Nephrology Providers 2
(Date:3/5/2015)... In 2014, the FDA approved 44 drugs, with ... scoring 4 drug approvals in the USA. The infectious ... drug products, followed by oncology therapy with 18% of ... CDK inhibitors keep on attracting large-cap pharmacos. Nivolumab and ... metastatic melanoma, and at present, they are being investigated ...
(Date:3/5/2015)... Alachua, FL (PRWEB) March 05, 2015 ... technology company focused on the peripheral nerve repair market, ... quarter ended December 31, 2014 compared to $2.98 million ... execution of its growth strategies. , “Our strong ... of our peripheral nerve repair products which is driving ...
(Date:3/5/2015)... 2015 HomeCEUConnection.com is proud ... extra savings on their nutrition CEUs. To ... and nutrition, HomeCEUConnection.com is offering 10% off ... code, NUTRITION2015 . , High Quality ... HomeCEUConnection.com provides high-quality continuing education courses for ...
(Date:3/5/2015)... March 05, 2015 TCS Healthcare Technologies ... for the population health management arena, is pleased to ... management software, ACUITY Advanced Care™ (ACUITY) version 7.20. The ... performance and the advantages of automation. , The webinar, ... will be led by Jeff Frater, RN, BSN, Director ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 University ... university founded in 1904, has launched a new ... positive lifestyle changes. The Northwest Center for Lifestyle ... professionals, support community outreach, and conduct research in ... medicine, diet and nutrition. The center will target ...
Breaking Medicine News(10 mins):Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 2Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 3Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 3Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 4Health News:HomeCEUConnection.com Offers Nutrition CEUs this March to Celebrate Nutrition Month 2Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 2Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 3Health News:University of Western States Launches Northwest Center for Lifestyle and Functional Medicine 2
... Anticipating the needs of,the future, Geneva College will ... in the nation., Drawing on Geneva,s long-standing ... the program offers students a M.S. degree in,Cardiovascular ... of obtaining a B.S. (in four years) or ...
... 28, 2008 Oxytocin was originally studied as the ... for breast-feeding. However, there is increasing evidence that ... bonding and maternal behaviors. A new study scheduled ... Biological Psychiatry now shows that one way oxytocin ...
... of Liverpool has found that hypnosis can slow down ... for those living with the condition. , Forensic psychologist, ... people living with dementia and compared the treatment to ... hypnosis compared to a type of group therapy in ...
... MASummer on Cape Cod is synonymous with a surge ... the MBL (Marine Biological Laboratory). For more than a ... from around the world to immerse themselves in biological ... organisms available for study and the wealth of experts ...
... more resistance, study found , , MONDAY, July 28 (HealthDay ... even act out when nurses or other caregivers use ... , Researchers who taped the interactions of nursing home ... residents often became more agitated and resistant to care ...
... LLC launches new website offering convenient http://www.terrimilen.com [Online Counseling ... the comfort of their own home or office. , ... ... to provide clients with an alternative to traditional therapy which requires ...
Cached Medicine News:Health News:Geneva Offers First Cardiovascular Technology Graduate Program in the Nation 2Health News:A hormone that enhances one's memory of happy faces 2Health News:LabBits: A media tip sheet from the MBL in Woods Hole 2Health News:LabBits: A media tip sheet from the MBL in Woods Hole 3Health News:LabBits: A media tip sheet from the MBL in Woods Hole 4Health News:Alzheimer's Patients React Poorly to 'Elderspeak' 2Health News:Alzheimer's Patients React Poorly to 'Elderspeak' 3Health News:Online Counseling and Life Coaching Practice Launches New Website 2
... The AEM Laparoscopic Instruments incorporate a layered ... are shielded and monitored to prevent stray ... instrument caused by insulation failure or capacitive ... protective shield built into all AEM Instruments ...
... Laparoscopic Instruments incorporate a layered design unique ... and monitored to prevent stray electrosurgical burns ... by insulation failure or capacitive coupling; a ... built into all AEM Instruments provides a ...
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
Medicine Products: